During the past decade, Montreal Heart Institute Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Heart Institute Research Center" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Montreal Heart Institute Research Center" are "Acute Coronary Syndrome (ACS)" (1 trials), "Heart Failure" (1 trials) and "Transthyretin (TTR) Amyloid Cardiomyopathy" (1 trials). Many other conditions were trialed in "Montreal Heart Institute Research Center" in a lesser frequency.

Most popular intervention types in "Montreal Heart Institute Research Center" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CRT off" (1 trials), "CRT on" (1 trials), "Heparin" (1 trials), "REG1" (1 trials) and "Tafamidis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Heart Institute Research Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Heart Institute Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Montreal Heart Institute Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Heart Institute Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Montreal Heart Institute Research Center has several departments that took part in Clinical trials: "Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute" - 13 trials, "Montreal Heart Institute" - 249 trials, "Institut de Cardiologie de Montreal" - 45 trials, "Cardiovascular prevention and rehabilitation center" - 5 trials